Emergent Respiratory Products was established in 2000. Emergent Respiratory Products is a privately held, emerging growth company that produces and markets the new PORTO2VENT CPAPos oxygen delivery system, an innovative respiratory device technology that assists breathing for sufferers of congestive heart failure (CHF), acute respiratory distress and other forms of dyspnea (difficulty breathing).